In 2004, Amin Rustom published findings in Science describing microscopic tubes that link cells and allow them to swap organelles and proteins, Knowable Magazine reported.
The discovery challenged the long-standing view of cells as isolated units that communicate only through direct contact or diffused signaling molecules. Rustom, then at Heidelberg University, observed the structures after skipping a step in a lab protocol; thin, translucent strands appeared connecting cultured rat tumor cells. He named them tunneling nanotubes.
Skepticism gives way to visual proof
Many scientists initially questioned whether the nanotubes were biological artifacts created by the experimental setup. “For many years, it was reasonable to question whether some of the structures being observed were biologically meaningful,” said Chiara Zurzolo, a neurobiologist at the Pasteur Institute in Paris, in an interview with Knowable Magazine.
Advances in imaging have since shifted the consensus. Cryo-electron microscopy now resolves the tubes at high resolution, and live imaging has captured them in living animals. Researchers have also observed nanotube-like structures in tumors removed from patients after surgery, though they have not yet been seen in living human tissue, Knowable Magazine reported.

“This has helped move the field beyond the original question of whether nanotubes exist toward more interesting questions about how they form and what functions they perform in different biological contexts,” Zurzolo told Knowable Magazine.
Structure and cargo
Tunneling nanotubes are typically a fraction of a cell’s diameter. They form when fibers within a cell push its membrane outward toward another cell, fusing to create an open-ended conduit, or when two contacting cells pull apart and leave a narrow bridge behind, according to Knowable Magazine.
Subsequent studies have found the structures in heart cells, stem cells, and neurons. Through them, cells transfer cargo ranging from single molecules to entire organelles — most notably mitochondria, which can rescue energy-depleted neighbors, and RNA, which can reprogram recipient cell behavior. “I liken them to skyways that connect buildings in cities,” said Emil Lou, an oncologist at the University of Minnesota, speaking to Knowable Magazine.
Stress triggers formation
Stress often triggers tunneling nanotube formation. Cells that are injured, deprived of oxygen or lacking in nutrients are more likely to produce them. Most often the distressed cell initiates the connection, but in certain cases damaged cells produce molecules that encourage healthy cells to initiate a connection, Knowable Magazine reported.
Cancer cells, under stress from rapid, disorganized growth, exploit these pathways to siphon mitochondria and other resources from surrounding tissue. French researchers found that mitochondrial transfer via nanotubes helped cancer cells survive the chemotherapy drug temozolomide.
Targeting nanotubes in cancer therapy
Derick Han, a molecular pharmacologist at Keck Graduate Institute in California, and colleagues used a fungal toxin that disrupts actin to suppress nanotube formation by more than 80 percent in breast cancer cells. The treatment improved the killing effectiveness of the chemotherapy drug 5-fluorouracil by 30 to 62 percent, according to research cited by Knowable Magazine.
A major hurdle is that actin and nanotubes serve essential roles throughout the body; indiscriminate blockade risks widespread side effects. Researchers are now seeking ways to selectively inhibit pathological nanotube formation without disrupting normal physiology.
Energizing immune cells
Luca Gattinoni, an immunologist at the Leibniz Institute for Immunotherapy in Germany, is pursuing the opposite strategy: using nanotubes to strengthen anti-cancer T cells. His team co-cultured stem cells with T cells, which often become exhausted and lose killing capacity. Nanotube connections allowed stem cells to donate mitochondria to the T cells.
“Ultimately this process allows T cells to fight cancer in a much more effective way,” Gattinoni said, as reported by Knowable Magazine. In lab dishes, mitochondria-boosted human T cells sustained leukemia killing through six rounds of attack, while unboosted T cells exhausted after three. In mice, the enhanced T cells reduced leukemia burden and extended survival.
Potential for treating nerve pain
Ru-Rong Ji, a pain researcher at Duke University School of Medicine, found that satellite glial cells surrounding sensory neurons act as mitochondrial donors via nanotubes. Transplanting healthy human glial cells into diabetic mice reduced pain sensitivity and improved mitochondrial function, measured by increased oxygen consumption. Disrupting Myosin 10, a protein required for nanotube formation, abolished the benefit, according to research cited by Knowable Magazine.
Founded in 1386, Heidelberg University is Germany’s oldest university, established by papal bull under Pope Urban VI. It has been coeducational since 1899 and operates twelve faculties across roughly 100 disciplines. As of 2021, 33 Nobel Prize winners have been affiliated with the university, which introduced scientific disciplines including modern psychiatry, psychopharmacology, and mathematical statistics. International students from some 130 countries account for more than 20 percent of the entire student body.
Barriers to clinical translation
Despite promising lab results, therapies remain distant. The inability to visualize nanotubes in living humans limits understanding of how nanotube-modulating treatments would work in patients.
Further research in isolated cells and animal models is needed to determine which nanotube-dependent interactions drive disease and which can be safely targeted. “The next step will be to determine which nanotube-dependent interactions matter most in patients and which can be safely targeted therapeutically,” Lou told Knowable Magazine.
Related reading